Adams Eric A
President &CEO
1 company
Insider Signal Score
19
WeakTrades Analyzed
5
12M Win Rate
0.0%
Avg 3M Return
-32.1%
Avg 12M Return
-83.8%
Adams Eric A is a President &CEO at InMed Pharmaceuticals Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $65K based on current market prices.
Holdings by Company
INMFeb 20, 2024
Current Shares44.0K
Value$65.5K
Net Activity+84.5K
Bought: 84.5KSold: 0
Transaction History
Showing 5 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 41,600 | $0.36 | $14,921.92 | +1,763% | -13.3% | -55.7% | |
| Apr 14, 2022 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 14,160 | $0.89 | $12,659.04 | +31.6% | -50.9% | -94.3% | |
| Apr 13, 2022 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 8,560 | $0.85 | $7,276.00 | +23.6% | -47.8% | -94.4% | |
| Sep 29, 2021 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 8,800 | $1.73 | $15,224.00 | +32.0% | -25.8% | -87.4% | |
| Sep 28, 2021 | INM Inmed Pharmaceuticals Inc. | President &CEO | Buy | 11,400 | $1.75 | $19,984.20 | +70.9% | -22.5% | -87.2% |